SUR, D.; HAVASI, A.; LUNGULESCU, C.; VOLOVAT, S.; BURZ, C.; IRIMIE, A. Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review. Medicine and Pharmacy Reports, 13 maio 2022.